First-time dog owners Jackie See and Judyvein Cheng bought the male dog as a four-month-old puppy in 2018 for $4,800 from a local backyard breeder.
Soon the married couple discovered Wangcai had mites, stomach issues, a yeast infection and rashes.
"As first-time pet owners, we felt anxious and helpless. We kept going to the vet to find out what was wrong and constantly switched from premium kibbles to a hypoallergenic diet from the clinic. We spent between $2,000 and $3,000 (on the vet visits and food), but his condition did not improve," Ms Cheng, an event organiser, told The Straits Times.
Wangcai was also given cytopoint, an antibody used to treat atopic dermatitis, a chronic condition he was diagnosed with which causes dry, itchy and inflamed skin, but his condition worsened.
"He was scratching more and that led to some open sores and bleeding every day. He also developed hives, redness in his groin, '‘armpit' area and between his toes, rashes on his belly, fur loss and scabs and dandruff-like flakes," Ms Cheng said.
"We realised we were treating the symptoms, not going to the root of the skin issue. The medication was affecting his immune system, and realising what we had put our baby through, I cried," she added.
After the vet said that Wangcai had to go back once every two weeks for the cytopoint injection, which cost around $400 each, and would be on antihistamine for the next six months, she and her event emcee husband felt that Wangcai had had enough medication.
They looked into changing his diet instead. After six months of trial and error, the couple settled on a diet that seemed to suit him.
When Wangcai was around two years old, his health turned around he stopped scratching incessantly and "became a normal dog". And the couple was $10,000 poorer.
"We went through 12 years of craziness. It was a steep learning curve providing care to Wangcai.
هذه القصة مأخوذة من طبعة September 16, 2024 من The Straits Times.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة September 16, 2024 من The Straits Times.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
HIT THE RAILS ON A BIKE
It is always a thrill to pull out of a train station and feel yourself picking up speed, wheels click-clacking over the rails.
From drugs, jail and bankruptcy to social enterprise cafe for ex-offenders
Drugs. Bankruptcy. Failed marriages. And prison. But Mr Matthew Poh is not letting his past define him.
Small Rain finds great intimacy amid medical isolation
How has the Covid-19 pandemic shaped literary fiction? American novelist Garth Greenwell's turn from two erotically charged novels set in Bulgaria to his latest – a pandemic novel set in the sexless emergency ward of an Iowa hospital – offers answers.
Grab Singapore's managing director listens to audiobooks
Mr Yee Wee Tang, 48, managing director of Grab Singapore, recently announced that the company has upgraded its Grab Benefits 2.0 programme and will spend $4 million a year on welfare for drivers and delivery workers who use the platform.
Japanese author inspired by external environs
Ko Shinjo is behind the novel that inspired Netflix hit Tokyo Swindlers
Gen Z couples say no to hawker centre first dates
In the light of a Bumble survey, The Sunday Times speaks to four couples to find out how dating etiquette has evolved over the years
Let's Talk About Death Who will care for my sister when I die?
Let's Talk About Death is a five-episode docuseries that follows several millennials and their loved ones as they navigate end-of-life planning, and seeks to kick-start honest conversations about death and dying well.
Maeder, kitefoiling get sweet Yeo's bundle deal
An already momentous year for Singapore's kitefoiler Maximilian Maeder got even better on Nov 9, when local food and beverage company Yeo Hiap Seng (Yeo's) extended their sponsorship deal by another four years from 2025 to 2028.
CAVENDISH'S FINAL RACE
Legend confirms that S'pore Criterium is his swansong - and he wants to claim it
Improving Chelsea can beat any team, says Maresca
UP FOR THE FIGHT